On March 31, 2014, zacks issued an updated research report on Canadian Solar Inc. (NASDAQ:CSIQ). One of the world’s largest solar power companies, Canadian Solar, swung into profit in 2013 as against the loss incurred in 2012, buoyed by an increase in shipment volume and higher revenues. Canadian Solar’s fourth quarter 2013 revenues beat the Zacks Consensus Estimate by 1.7% and were a whopping 76.2% higher than the year-ago number. Canadian Solar Inc. (NASDAQ:CSIQ) shares after opening at $29.93 moved to $30.00 on last trade day and at the end of the day closed at $26.68. Company price to sales ratio in past twelve months was calculated as 0.87 and price to cash ratio as 6.29. Canadian Solar Inc. (NASDAQ:CSIQ) showed a negative weekly performance of -17.68%.
Monster Beverage Corp (NASDAQ:MNST) revenue growth came in higher than the industry average of 4.0%. Since the same quarter one year prior, revenues rose by 14.7%. This growth in revenue appears to have trickled down to the company’s bottom line, improving the earnings per share. Monster Beverage Corp (NASDAQ:MNST) shares fell -7.04% in last trading session and ended the day on $64.04. MNST return on equity ratio is recorded as 45.80% and its return on assets is 29.80%. Monster Beverage Corp (NASDAQ:MNST) yearly performance is 14.64%.
SunPower Corporation (NASDAQ:SPWR) installed 149 kilowatt solar power system on the rooftop of stores and warehouses of Watershed Premium Wines (Watershed) In Australia. SunPower Corporation (NASDAQ:SPWR) shares moved down -7.58% in last trading session and was closed at $28.04, while trading in range of $27.68 – $30.70. SunPower Corporation (NASDAQ:SPWR) year to date (YTD) performance is -5.94%.
ACADIA Pharmaceuticals (NASDAQ:ACAD) Director Torsten Rasmussen sold 30,000 shares of the company’s stock on the open market in a transaction dated Friday, April 4th. The stock was sold at an average price of $21.98, for a total transaction of $659,400.00. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) weekly performance is -13.10%. On last trading day company shares ended up $20.04. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) distance from 50-day simple moving average (SMA50) is -21.01%. Analysts mean target price for the company is $31.50.
Leave a Reply